You are here: Geisinger Medical
Laboratories > Test
Catalog
Geisinger Medical Laboratories Test Catalog
CULTURE, CYSTIC FIBROSIS |
||
ORDERING INFORMATION: |
Geisinger Epic Procedure Code: LAB2128 Geisinger Epic ID: 14859 | |
SPECIMEN COLLECTION |
||
Specimen type: |
Respiratory specimen from patients with cystic fibrosis | |
Preferred collection container: |
||
Alternate Collection Container: |
Sputum Collector
Collection Trap
|
|
Special notes: |
Check expiration date on transport device before use. | |
Patient preparation: |
Patient instruction required (see Microbiology Collection Appendix Sputum Collection Guidelines) | |
| SPECIMEN PROCESSING |
||
Transport temperature: |
Room temperature | |
Specimen stability: |
Unpreserved specimens, room temperature, < 24 hours Swabs, room temperature, < 72 hours |
|
Rejection criteria: |
Improperly labeled/identified specimen. Expired collection device/swab. Grossly contaminated specimen. Delay in transport or transport at wrong temperature. | |
TEST DETAILS |
||
Reference interval: |
No growth or normal pharyngeal flora | |
CPT code(s): |
87070 | |
| Note: The billing party has sole responsibility for CPT coding. Any questions regarding coding should be directed to the payer being billed. The CPT codes provided by GML are based on AMA guidelines and are for informational purposes only. | ||
Test includes: |
Isolation, identification, and semiquantitation of aerobic respiratory pathogens. Bacterial identification and antibiotic susceptibility testing performed as appropriate. Additional charges may apply. | |
Methodology: |
Culture |
|
Synonyms: |
CYSTIC FIBROSIS CF, CFC CULTURE
|
|
Clinical significance: |
Diagnosis of microbial pathogens from patients with cystic fibrosis requires special culture methods and culture media that are included in the CF culture. All potential respiratory tract pathogens are identified, with antimicrobial susceptibility testing performed when clinically appropriate. | |
Doctoral Director(s:) |
Donna Wolk PhD, D(ABMM), Raquel Martinez, PhD, D(ABMM) | |
| Review Date: | 12/31/2022 | |